Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2011

May 17, 2011

32337_dirs_2011-05-17_67b18bfa-8f8c-4bb3-87ed-c2fcca3b1300.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2011-05-13

Reporting Person: Hienrich Edi (SVP/Managing Director EMEA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-13 Common Stock S 2802 $106.86 Disposed 7901 Direct
2011-05-13 Common Stock M 3600 $15.00 Acquired 4271 Indirect
2011-05-13 Common Stock S 3600 $106.98 Disposed 671 Indirect
2011-05-13 Common Stock M 2478 $45.88 Acquired 10379 Direct
2011-05-13 Common Stock D 1716 $106.75 Disposed 8663 Direct
2011-05-13 Common Stock M 1800 $43.13 Acquired 2471 Indirect
2011-05-13 Common Stock D 1222 $106.75 Disposed 1249 Indirect
2011-05-13 Common Stock M 434 $32.79 Acquired 1683 Indirect
2011-05-13 Common Stock D 273 $106.75 Disposed 1410 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-13 Non-Qualified Stock Option (Right to Buy) $15.00 M 3600 Disposed 2015-04-27 Common Stock (3600) Indirect
2011-05-13 Stock Appreciation Rights $45.88 M 2478 Disposed 2020-05-07 Common Stock (2478) Direct
2011-05-13 Stock Appreciation Rights $43.13 M 1800 Disposed 2018-02-28 Common Stock (1800) Indirect
2011-05-13 Stock Appreciation Rights $32.79 M 434 Disposed 2006-03-23 Common Stock (434) Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $106.84 to $106.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: These options were fully vested as of March 30, 2010.

F3: Consists of stock appreciation rights granted under the Herbalife Ltd. 2005 Stock Incentive Plan, of which 20% vested on May 7, 2011, 20% will vest on May 7, 2012 and the remaining 60% will vest on May 7, 2013.

F4: These stock appreciation rights were fully vested as of February 28, 2011.

F5: These stock appreciation rights were fully vested as of December 31, 2010.